Skip to main content
Top
Published in: International Journal of Hematology 5/2017

01-11-2017 | Original Article

Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016

Authors: Akiko Miyagi Maeshima, Hirokazu Taniguchi, Tomotaka Suzuki, Sayako Yuda, Kosuke Toyoda, Nobuhiko Yamauchi, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Dai Maruyama, Yukio Kobayashi, Kensei Tobinai

Published in: International Journal of Hematology | Issue 5/2017

Login to get access

Abstract

We analyzed the distribution of tumors and lymphomas of the anterior mediastinum diagnosed between 1997 and 2016 at the National Cancer Center Hospital, Japan. The median age of 283 patients with anterior mediastinal tumors was 48 (range 6–84) years, and 143 (51%) were male. The incidence of tumors was as follows: thymoma, 34%; thymic carcinoma, 16%; primary mediastinal large B-cell lymphoma (PMBL), 13%; germ cell tumors, 10%; classical Hodgkin lymphoma (CHL), 9%; thymic cyst, 7%; metastatic tumors, 3%; T lymphoblastic leukemia/lymphoma (T-LBL), 2%; other lymphomas, 3%; and others, 3%. Of the newly diagnosed lymphomas in 60 patients, PMBL (46%) was the most frequent, followed by CHL (32%), T-LBL (12%), mucosa-associated lymphoid tissue lymphoma (3%), and other lymphomas (7%). These findings suggest a recent increase in PMBL in Japan. The frequency and subtype of lymphoma differ with age and sex. In female patients ≤40 years old, 58% of the anterior mediastinal tumors were PMBL (39%) or CHL (19%). Germ cell tumors were the most frequent in male patients ≤40 years old, followed by CHL (21%), PMBL (17%), and T-LBL (10%). This distribution may serve as a reference for routine histologic diagnosis of lymphomas in the anterior mediastinum in Japan.
Literature
1.
go back to reference Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. World Health Organization Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2015. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. World Health Organization Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2015.
2.
go back to reference Ueda R, Maruyama D, Nomoto J, Maeshima AM, Fukuhara S, Kitahara H, et al. FUS-ERG gene fusion in isolated myeloid sarcoma showing uncommon clinical features. Oxf Med Case Rep. 2016;2016:4–8.CrossRef Ueda R, Maruyama D, Nomoto J, Maeshima AM, Fukuhara S, Kitahara H, et al. FUS-ERG gene fusion in isolated myeloid sarcoma showing uncommon clinical features. Oxf Med Case Rep. 2016;2016:4–8.CrossRef
3.
go back to reference Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, et al. A child case of CD34+, CD33+, HLA-DR−, CD7+, CD56+ stem cell leukemia with thymic involvement. Leuk Res. 1996;20:983–5.CrossRefPubMed Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, et al. A child case of CD34+, CD33+, HLA-DR−, CD7+, CD56+ stem cell leukemia with thymic involvement. Leuk Res. 1996;20:983–5.CrossRefPubMed
4.
go back to reference Yagci B, Varan A, Uner A, Akyuz C, Buyukpamukcu M. Thymic langerhans cell histiocytosis mimicking lymphoma. Pediatr Blood Cancer. 2008;51:833–5.CrossRefPubMed Yagci B, Varan A, Uner A, Akyuz C, Buyukpamukcu M. Thymic langerhans cell histiocytosis mimicking lymphoma. Pediatr Blood Cancer. 2008;51:833–5.CrossRefPubMed
5.
go back to reference Wu W, Cao L, Li Y, Yu X, Huang H, He J. Primary splenic diffuse large B-cell lymphoma in a patient with thymus Rosai–Dorfman disease. Am J Med Sci. 2012;344:155–9.CrossRefPubMed Wu W, Cao L, Li Y, Yu X, Huang H, He J. Primary splenic diffuse large B-cell lymphoma in a patient with thymus Rosai–Dorfman disease. Am J Med Sci. 2012;344:155–9.CrossRefPubMed
6.
go back to reference Takamori S, Yano H, Hayashi A, Fukunaga M, Miwa K, Maeshiro K, et al. Amyloid tumor in the anterior mediastinum: report of a case. Surg Today. 2004;34:518–20.CrossRefPubMed Takamori S, Yano H, Hayashi A, Fukunaga M, Miwa K, Maeshiro K, et al. Amyloid tumor in the anterior mediastinum: report of a case. Surg Today. 2004;34:518–20.CrossRefPubMed
7.
go back to reference Yamashita A, Saito T, Akaike K, Arakawa A, Yoshida A, Kikuchi K, et al. Mast cell sarcoma of the sternum, clonally related to an antecedent germ cell tumor with a novel D579del KIT mutation. Virchows Arch. 2017;470:583–8.CrossRefPubMed Yamashita A, Saito T, Akaike K, Arakawa A, Yoshida A, Kikuchi K, et al. Mast cell sarcoma of the sternum, clonally related to an antecedent germ cell tumor with a novel D579del KIT mutation. Virchows Arch. 2017;470:583–8.CrossRefPubMed
8.
go back to reference Aoki R, Karube K, Sugita Y, Nomura Y, Shimizu K, Kimura Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006. Pathol Int. 2008;58:174–82.CrossRefPubMed Aoki R, Karube K, Sugita Y, Nomura Y, Shimizu K, Kimura Y, et al. Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006. Pathol Int. 2008;58:174–82.CrossRefPubMed
9.
go back to reference Barth TF, Leihauser F, Joos S, Bentz M, Moller P. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancer Oncol. 2002;3:229–34.CrossRef Barth TF, Leihauser F, Joos S, Bentz M, Moller P. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancer Oncol. 2002;3:229–34.CrossRef
10.
go back to reference Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d’Agay MF, Baumelou E, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 non-mediastinal large B-cell lymphomas, a GELA (“Groupe d’Etude des lymphomes de l’Adulte”) study. Am J Surg Pathol. 1996;20:877–88.CrossRefPubMed Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d’Agay MF, Baumelou E, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 non-mediastinal large B-cell lymphomas, a GELA (“Groupe d’Etude des lymphomes de l’Adulte”) study. Am J Surg Pathol. 1996;20:877–88.CrossRefPubMed
11.
go back to reference Osumi T, Tanaka F, Mori T, Fukano R, Tsurusawa M, Oshima K, et al. Primary mediastinal large B-cell lymphoma in Japanese children and adolescents. Int J Hematol. 2017;105:440–4.CrossRefPubMed Osumi T, Tanaka F, Mori T, Fukano R, Tsurusawa M, Oshima K, et al. Primary mediastinal large B-cell lymphoma in Japanese children and adolescents. Int J Hematol. 2017;105:440–4.CrossRefPubMed
12.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organization classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. World Health Organization classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
13.
go back to reference Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.CrossRefPubMedPubMedCentral Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.CrossRefPubMedPubMedCentral
14.
go back to reference Williams AS, Shawwa A, Merrimen J, Dakin Haché K. Expression of OCT4 and SALL4 in diffuse large B-cell lymphoma: an analysis of 145 consecutive cases and testicular lymphomas. Am J Surg Pathol. 2016;40:950–7.CrossRefPubMed Williams AS, Shawwa A, Merrimen J, Dakin Haché K. Expression of OCT4 and SALL4 in diffuse large B-cell lymphoma: an analysis of 145 consecutive cases and testicular lymphomas. Am J Surg Pathol. 2016;40:950–7.CrossRefPubMed
Metadata
Title
Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997–2016
Authors
Akiko Miyagi Maeshima
Hirokazu Taniguchi
Tomotaka Suzuki
Sayako Yuda
Kosuke Toyoda
Nobuhiko Yamauchi
Shinichi Makita
Suguru Fukuhara
Wataru Munakata
Dai Maruyama
Yukio Kobayashi
Kensei Tobinai
Publication date
01-11-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2331-0

Other articles of this Issue 5/2017

International Journal of Hematology 5/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine